Connect with us

Health

AstraZeneca Vaccine Faces Another Setback After Independent Board Questions Trial Data

Published

on

UNICEF Takes 1.3m DR Congo Vaccines To Avoid Expiry

One of the findings from some U.S. federal health officials indicates Oxford-AstraZeneca’s COVID-19 vaccine may have provided an incomplete or outdated efficacy data.

AstraZeneca earlier reported on Monday its COVID-19 vaccine provides strong protection among adults of all ages.

The company insists that, in the study of 30,000 persons, there were no severe illnesses or hospitalizations among vaccinated volunteers.

AstraZeneca also said the study’s independent safety monitors found no serious side effects, including increased risk of rare blood clots.

US officials now say authorization and guidelines for use of the vaccine in the united states will be determined by the food and drug administration and centers for disease control and prevention after thorough review of the data by independent advisory committees.

Meanwhile, a top European Union official, Sandra Galina has spoken out against the AstraZeneca vaccine company’s delay in producing doses for the 27-nation bloc.

Galina, who is chief of the European Commission’s health division, told legislators on Tuesday, while Pfizer and Moderna have largely met their commitments, AstraZeneca seems to have issues with meeting up with demands.

Galina blames the European Union’s slow rollout of vaccines on AstraZeneca vaccine, which was supposed to be the workforce of the drive, because it is cheaper and easier to transport and was supposed to be delivered in huge amounts in the first half of the year.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Oyo State: Two Persons Die Of COVID-19 Delta Variant

Published

on

By

Two Persons Die Of Covid-19 Delta Variant In Oyo

Two persons have been reported killed in Oyo State after been infected with the deadly COVID-19 Delta variant.

The state incident manager and coordinator of the emergency operations centre, Dr. Olabode Ladipo said one other person is in state isolation facility and receiving medical attention.

Oyo state government announced on Sunday it had found the Delta strain of the coronavirus which entered into the state through movement of people travelling around the world.

W.H.O. said this variant first detected in India and now in at least 90 countries, has high transmission, and increase severity of infection.

Authorities in the state said they have begun contact tracing and urged the general public to take extra caution.

Continue Reading

Health

Oyo State Confirms COVID-19 Delta Variant

Published

on

By

Oyo State task force on COVID-19 says the deadly delta variant has now been detected in Oyo. The state incident manager and coordinator of the emergency operations centre, Dr. Olabode Ladipo, notified the public in a statement on Sunday asking the general public to take extra caution. The delta strain has been associated with high transmission, increase severity of infection and outcomes.

Last week Thursday, the Nigeria Centre for Disease Control (NCDC) had said on Thursday, the coronavirus delta variant first discovered in India has been confirmed in Nigeria, in a traveller, following the routine travel test made compulsory for all international travellers.

In a latest data released today Monday, NCDC says 12 new COVID-19 cases have been reported from 3 states- Akwa Ibom (6), Ogun (4), and Rivers 2 cases, bringing the total number of persons who have tested positive in the country to 168,552 and 2,124 deaths.

The variant, has already been detected in more than 90 countries, and is expected to spread to others.

Oyo COVID-19 task force has warned residents of the state to continue complying all advisories at curtailing the spread of the virus.

Continue Reading

Health

COVID-19 Third Wave Overwhelm French Hospitals

Published

on

By

COVID-19 Third Wave Overwhelm French Hopsitals

Continue Reading

Trending

Copyright © 2021 Africa News Network.